BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 8094901)

  • 1. "Infectious" transplantation tolerance.
    Qin S; Cobbold SP; Pope H; Elliott J; Kioussis D; Davies J; Waldmann H
    Science; 1993 Feb; 259(5097):974-7. PubMed ID: 8094901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance and suppression in a primed immune system.
    Marshall SE; Cobbold SP; Davies JD; Martin GM; Phillips JM; Waldmann H
    Transplantation; 1996 Dec; 62(11):1614-21. PubMed ID: 8970617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rejection of discordant skin xenografts by CD4- CD8- TCR alpha beta+ cells in CD4- and CD8-deficient mice.
    Umesue M; Mayumi H; Kong YY; Omoto K; Muranaka H; Nakanishi R; Kohno H; Yasumoto K; Kishihara K; Nomoto K
    Transplant Proc; 1999; 31(1-2):890-1. PubMed ID: 10083391
    [No Abstract]   [Full Text] [Related]  

  • 4. CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression.
    Honey K; Cobbold SP; Waldmann H
    J Immunol; 1999 Nov; 163(9):4805-10. PubMed ID: 10528180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linked suppression of skin graft rejection can operate through indirect recognition.
    Wise MP; Bemelman F; Cobbold SP; Waldmann H
    J Immunol; 1998 Dec; 161(11):5813-6. PubMed ID: 9834057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant tolerance and linked suppression induced by therapeutic antibodies do not depend on Fas-FasL interactions.
    Honey K; Cobbold SP; Waldmann H
    Transplantation; 2000 Apr; 69(8):1683-9. PubMed ID: 10836381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection.
    Oliveira V; Sawitzki B; Chapman S; Appelt C; Gebuhr I; Wieckiewicz J; Long E; Wood KJ
    Eur J Immunol; 2008 Jun; 38(6):1677-88. PubMed ID: 18465768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo.
    Hara M; Kingsley CI; Niimi M; Read S; Turvey SE; Bushell AR; Morris PJ; Powrie F; Wood KJ
    J Immunol; 2001 Mar; 166(6):3789-96. PubMed ID: 11238621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants.
    Cobbold SP; Castejon R; Adams E; Zelenika D; Graca L; Humm S; Waldmann H
    J Immunol; 2004 May; 172(10):6003-10. PubMed ID: 15128783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin allograft maintenance in a new synchimeric model system of tolerance.
    Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of long-term H-Y-specific tolerance in female mice given male lymphoid cells while transiently depleted of CD4+ or CD8+ T cells.
    VanderVegt FP; Johnson LL
    J Exp Med; 1993 Jun; 177(6):1587-92. PubMed ID: 8098730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
    Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between tacrolimus and cyclosporine as immunosuppressive agents compatible with tolerance induction by CD4/CD8 blockade.
    Moffatt SD; Metcalfe SM
    Transplantation; 2000 Apr; 69(8):1724-6. PubMed ID: 10836388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of double-negative regulatory T cells in long-term cardiac xenograft survival.
    Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L
    J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejection of transgenic skin expressing a xeno-class I antigen is CD4-dependent and CD8-independent.
    Auchincloss H; Moses R; Conti D; Sundt T; Smith C; Sachs DH; Winn HJ
    Transplant Proc; 1990 Jun; 22(3):1059-60. PubMed ID: 1971971
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.
    Kitagawa S; Sato S; Hori S; Hamaoka T; Fujiwara H
    J Exp Med; 1990 Jul; 172(1):105-13. PubMed ID: 2141624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance induction in the adult using monoclonal antibodies to CD4, CD8, and CD11a (LFA-1).
    Waldmann H; Cobbold SP; Qin S; Benjamin RJ; Wise M
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():885-92. PubMed ID: 2484253
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.
    van Maurik Av; Herber M; Wood KJ; Jones ND
    J Immunol; 2002 Nov; 169(10):5401-4. PubMed ID: 12421913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
    Kingsley CI; Karim M; Bushell AR; Wood KJ
    J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.